KalVista Pharmaceuticals, Inc.

NASDAQ:KALV

12.6 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32002 Q22002 Q12001 Q3
Revenue 0001.2060000000000012.690003.8241.5773.923.3692.9263.895.5923.7184.842.3311.1270.0960.1140.24800.0070.0070.0080.0070.0070.0070.0080.010.0050.0060.398033.5790
Cost of Revenue 000.2240.2190.2070.1970.1990.3240.2090.19218.1860.182000000000000000000000000000000000000
Gross Profit 00-0.2240.987-0.207-0.197-0.199-0.324-0.209-0.192-18.186-0.18200012.690003.8241.5773.923.3692.9263.895.5923.7184.842.3311.1270.0960.1140.24800.0070.0070.0080.0070.0070.0070.0080.010.0050.0060.398033.5790
Gross Profit Ratio 0000.81800000000000100011111111111111011111111111010
Reseach & Development Expenses 12.59416.6126.61425.24822.52319.08919.30723.95120.06318.07718.18619.21319.73817.54613.66911.8779.0979.14811.1659.48511.2339.7899.68611.1397.657.8768.3565.8524.5484.3613.4762.9963.3390.3320.3323.5324.263.5334.5043.9023.0312.0881.751.4251.11618.077-3.21120.063
General & Administrative Expenses 30.34629.20117.60123.20710.62810.6579.7867.7776.8827.8068.137.5986.9456.0575.8476.1653.563.6333.2783.2963.0683.423.2473.0472.92.6092.3711.9572.1292.7032.0732.2045.0262.082.081.5431.3171.3731.171.0060.7941.490.6910.4370.3687.80606.882
Selling & Marketing Expenses 0000.207-0.2070000000000000000000000000000000000000000000
SG&A 30.34629.20117.60122.98810.42110.6579.7867.7776.8827.8068.137.5986.9456.0575.8476.1653.563.6333.2783.2963.0683.423.2473.0472.92.6092.3711.9572.1292.7032.0732.2045.0262.082.081.5431.3171.3731.171.0060.7941.490.6910.4370.3687.80606.882
Other Expenses 000-7.3452.3192.6192.3974.2884.3133.4943.5493.4384.1563.9433.1842.6392.1712.1862.9322.4982.9232.3212.0892.5111.7331.6161.8231.9850.9850.8670.5551.0190.66104.88-0.003-0.0030.001-0.0010.553-0.335-0.071-0.117-0.079-0.06303.2330
Operating Expenses 42.9445.81144.21548.23632.94429.74629.09331.72826.94525.88326.31626.81126.68323.60319.51618.04212.65712.78114.44312.78114.30113.20912.93314.18610.5510.48510.7277.8096.6777.0645.5495.28.3652.4122.4125.0755.5774.9065.6744.9083.8253.5782.4411.8621.48425.8830.02226.945
Operating Income -42.94-45.811-44.215-48.455-33.151-29.746-29.093-31.728-26.945-25.883-26.316-26.811-26.683-23.603-19.516-18.042-12.657-12.781-14.443-8.957-12.724-9.289-9.564-11.26-6.66-4.893-7.009-2.969-4.346-5.937-5.453-5.086-8.117-2.405-2.405-6.528-5.569-4.899-5.667-4.901-3.817-3.568-2.436-1.856-1.086-22.2570-21.303
Operating Income Ratio 000-40.17800000000000-1.422000-2.342-8.068-2.37-2.839-3.848-1.712-0.875-1.885-0.613-1.864-5.268-56.802-44.614-32.730-343.571-932.571-696.125-699.857-809.571-700.143-477.125-356.8-487.2-309.333-2.729000
Total Other Income Expenses Net -1.3223.5433.7723.8054.1232.0963.7765.4235.6423.6263.2742.6984.2163.9533.4073.0852.6092.3553.6292.2493.4333.3862.2262.8582.7041.5891.9792.312-0.8880.9510.5250.8840.47304.5791.347-0.09-0.092-3.345-0.283-0.897-0.427-0.199-0.159-0.1210-49.6660
Income Before Tax -44.262-42.268-40.443-44.65-29.028-27.65-25.317-26.305-21.303-22.257-23.042-24.113-22.467-19.65-16.109-14.957-10.048-10.426-10.814-6.709-9.291-5.903-7.338-8.402-3.956-3.304-5.03-0.657-5.234-4.986-4.928-4.202-7.6440-2.385-6.607-5.659-4.991-9.012-5.184-4.714-3.995-2.635-2.015-1.207-22.257-16.109-21.303
Income Before Tax Ratio 000-37.02300000000000-1.179000-1.754-5.892-1.506-2.178-2.871-1.017-0.591-1.353-0.136-2.245-4.424-51.333-36.86-30.8230-340.714-943.857-707.375-713-1,287.429-740.571-589.25-399.5-527-335.833-3.0330-0.480
Income Tax Expense 4.247000.85600.523-1.37913.728-6.971-3.7580.275-1.958-4.276-3.963-3.63-3.532-3.047-2.524-4.326-0.124-3.943-3.946-1.7730.124-2.952-1.358-2.046-2.5742.775-1.034-0.493-0.744-0.4730-0.020.3860.090.0960.0923.1770.8970.4270.1990.1590.121016.1090
Net Income -48.509-42.268-40.443-44.65-29.028-27.65-25.317-40.033-14.332-18.499-23.042-22.155-22.467-19.65-16.109-14.957-10.048-10.426-10.814-6.585-9.291-5.903-7.338-8.526-3.956-3.304-5.03-0.657-5.234-4.986-4.928-4.202-7.6440-2.365-6.607-5.659-4.991-9.012-5.184-4.714-3.995-2.635-2.015-1.207-22.257-16.109-21.303
Net Income Ratio 000-37.02300000000000-1.179000-1.722-5.892-1.506-2.178-2.914-1.017-0.591-1.353-0.136-2.245-4.424-51.333-36.86-30.8230-337.857-943.857-707.375-713-1,287.429-740.571-589.25-399.5-527-335.833-3.0330-0.480
EPS -0.92-0.91-0.87-1.02-0.84-0.8-0.74-1.17-0.51-0.75-0.94-0.9-0.92-0.8-0.66-0.66-0.56-0.58-0.61-0.37-0.52-0.33-0.42-0.5-0.23-0.22-0.47-0.061-0.49-0.5-0.51-0.43-10-0.5-3.51-3.01-2.65-5.58-4.43-6.5-5.51-3.64-2.78-1.67-0.001-0.001-0.001
EPS Diluted -0.92-0.91-0.87-1.02-0.84-0.8-0.74-1.17-0.51-0.75-0.94-0.9-0.92-0.8-0.66-0.65-0.56-0.58-0.61-0.37-0.52-0.33-0.42-0.49-0.23-0.22-0.47-0.061-0.49-0.5-0.51-0.43-10-0.5-3.51-3.01-2.65-5.58-4.43-6.5-5.51-3.64-2.78-1.67-0.001-0.001-0.001
EBITDA -41.191-45.584-43.991-44.431-32.944-29.549-28.9-31.54-26.746-25.71-26.158-26.655-26.534-23.476-19.384-17.902-12.521-12.648-14.315-8.827-12.59-9.162-9.443-11.138-6.557-4.79-6.959-2.918-4.296-5.89-5.421-5.075-8.108-2.4050-6.528-5.536-4.866-5.632-4.901-4.135-3.621-2.542-1.925-1.143-22.2570.132-21.303
EBITDA Ratio 000-39.99700000000000-1.432000-2.182-7.979-2.446-2.627-3.837-1.749-0.815-1.89-0.668-1.033-5.3-56.135-43.386-31.9440-340.714-717.857-692-694.714-804.571-616.714-516.875-362.1-508.4-320.833-2.87200.0040